Article
Intratumoral Heterogeneity of HER2/neu in Breast Cancer?A Rare Event
20 Feb 2007
Abstract excerpt
HER2/neu is overexpressed in about 20% of invasive breast carcinomas. Numerous studies have shown that there is high level of concordance between the HER2/neu status of the primary breast cancer and the metastases of a given patient. Recently, changes in HER2/neu status with tumor progression have been reported, suggesting the possibility of an emerging different tumor clone. Little is known about intratumoral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
